Curated Resources

Below is a list of selected resources for this topic area that the College has discovered and believes are relevant to our members. These resources are curated by the College but are not directly developed or administered by the College. For the learning activities developed by the college for this topic, please visit the Course Catalog.

 

Allergy Diagnostic Testing image

Delivery MethodOwnerYearCMECostNotes
Reading (Article, PDF, etc.)WAO20140.00$0.00 
Credit for the first skin testing goes to Charles H. Blackley, who in 1865 abraded a quarter-inch area of his skin with a lancet, applied grass pollen on a piece of wet lint, and covered the scarified area with an occlusive bandage. This resulted in intense itching and a very large cutaneous response. This brief article presentsx the history, types, devices, scoring and other aspects of skin testig.

Asthma Drug Found Highly Effective in Treating Chronic, Severe Hives and Itch image

Delivery MethodOwnerYearCMECostNotes
Reading (Article, PDF, etc.)Johns Hopkins20130.00$0.00 
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash.

Atopic Dermatitis eYardstick

Delivery MethodOwnerYearCMECostNotes
E-LearningACAAI20180.00$0.00 
The Atopic Dermatitis (AD) eYardstick helps allergists and dermatologists support patients who require additional steps in their therapy to relieve the pain, itch and suffering caused by AD.

Chronic Idiopathic Urticaria: A Primer on Identification and Treatment image

Delivery MethodOwnerYearCMECostNotes
E-LearningMedscape20140.50$0.00Video ; Valid for credit through 08/28/2015
The goal of this activity is to identify the characteristics of chronic urticaria for differential diagnosis and determine treatment strategies based on presenting symptoms and response to recommended treatments. Upon completion of this activity, participants will be able to: Identify the characteristics of chronic urticaria for differential diagnosis Determine treatment strategies for chronic urticaria based on presenting symptoms and response to recommended treatments

Clinical Cases: Atopic Dermatitis image

Delivery MethodOwnerYearCMECostNotes
E-LearningAAAAI20140.25$0.00Expires: 06/30/2014
These cases, developed by members of the Allergic Skin Diseases Committee of the AAAAI, will test familiarity with the current clinical evidence and recommendations for the treatment of allergic skin disease.

Eczema (E), Atopic Eczema (AE) and Atopic Dermatitis (AD) image

Delivery MethodOwnerYearCMECostNotes
Reading (Article, PDF, etc.)WAO20140.00$0.00 
Eczema (E) (also called atopic dermatitis (AD)) is an inflammatory, chronically relapsing, non-contagious and extremely pruritic skin disease. The discussion about pathogenesis of this disease is mirrored by the different names that it has been given ("prurigo Besnier," "neurodermitis," "endogenous eczema," etc.). Atopy is a strikingly common finding in these patients. The Nomenclature Task Force of the European Academy of Allergology and Clinical Immunology (EAACI) proposed the term the Atopic Eczema/Dermatitis Syndrome (AEDS) for this disease, since IgE is not a prerequisite in all patients. The World Allergy Organization 2003 Nomenclature Task force recommended that under the umbrella term dermatitis, eczema is now the agreed term to replace the transitional term atopic eczema/dermatitis syndrome (AEDS). Atopic eczema is eczema with demonstrable IgE association

Urticaria and Angioedema: Synopsis image

Delivery MethodOwnerYearCMECostNotes
Reading (Article, PDF, etc.)WAO20140.00$0.00 
Urticarial lesions itch, have a central white wheal that is elevated, and are surrounded by an erythematous halo. The lesions are typically rounded and circumscribed. Characteristically, hives should blanch with pressure; they generally resolve within 24 hours, leaving no residual change to the skin. The redness, which is augmented by local neural reflexes, is due to dilated blood vessels in superficial layers of the skin; the wheal is due to leakage of these vessels as fluid extravasates and compresses the vessels beneath it so that the central area appears clear.

WAO Conversations with Experts: Aspirin and How it Relates to Urticaria image

Delivery MethodOwnerYearCMECostNotes
Podcast (MP3, etc.)World Allergy Organization (WAO)20110.00$0.00MP3 Format, 13.8 MB
Hae-Sim Park, MD, PhD Ajou University School of Medicine South Korea Conducted by: Richard F. Lockey, MD

WAO Conversations with Experts: Genetics, Atopic Dermatitis and Asthma image

Delivery MethodOwnerYearCMECostNotes
Podcast (MP3, etc.)World Allergy Organization (WAO)20090.00$0.00MP3 Format, 2.7 MB
Malcolm N. Blumenthal, MD University of Minnestoa Medical Center Minneapolis, Minnesota (USA) Conducted by: Allen P. Kaplan, MD

WAO Conversations with Experts: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) image

Delivery MethodOwnerYearCMECostNotes
Podcast (MP3, etc.)World Allergy Organization (WAO)20090.00$0.00MP3 Format, 2.6 MB
Maja Mockenhaupt, MD Universitats-Hautklinik Freiburg Freiburg, Germany Conducted by: Bob Q. Lanier, MD

WAO Online Learning Module: Chronic Urticaria/Angioedema image

Delivery MethodOwnerYearCMECostNotes
E-LearningWorld Allergy Organization (WAO)20140.50$0.00Active until April 30, 2017
On completion of this interactive learning program, you will be able to 1) Describe an evidence-based and cost-effective diagnostic approach for patients with chronic urticaria/angioedema; 2) Identify patients with physical urticaria/angioedema; 3) Relate aspects of history and physical examination that would lead a clinician to differentiate leukocytoclastic vasculitis from chronic urticaria; 4) Describe the role of autoimmunity in the pathogenesis of urticaria/angioedema; 5) Describe an evidence-based stepwise approach to therapy of chronic urticaria; 6) Recognize patients with refractory chronic urticaria/angioedema; 7) Discuss recent evidence demonstrating the therapeutic utility of anti-Ige therapy for patients with antihistamine-resistant urticaria/angioedema.

WAO Online Learning Module: Latex Allergy image

Delivery MethodOwnerYearCMECostNotes
E-LearningWorld Allergy Organization (WAO)20140.50$0.00Active until April 30, 2017
One completion of this interactive learning program, you should be able to: 1) Define latex allergy and describe its epidemiology; 2) Identify the symptoms of latex allergy and its related conditions; 3) Explain treatment options for latex allergy; and 4) Discuss how to use latex or alternative products safely in the workplace to minimize/prevent latex allergy.

Suggestions for other resources to go on this page? Use "comments" below to let us know!